A case of short-coupled premature ventricular beat-induced ventricular fibrillation with early repolarization in the inferolateral leads

Journal of Arrhythmia
Hidekazu KondoNaohiko Takahashi

Abstract

This case report describes a 19-year-old man with early repolarization (ER) in the inferolateral leads and a normal QT interval who survived a cardiac arrest that was likely related to polymorphic ventricular tachycardia (VT). Electrocardiograms (ECGs) also showed unifocal premature ventricular beats (PVBs) with a relatively narrow QRS duration. A Holter ECG documented occasional short-coupled PVBs following non-sustained VTs. Pharmacological stress testing was also performed to assess the effects of anti-arrhythmic drugs on ER (the J wave) and PVBs. We performed successful radiofrequency catheter ablation to prevent the recurrence of ventricular fibrillation after cardioverter-defibrillator implantation.

References

May 1, 1996·Journal of the American College of Cardiology·R F Gilmour, N S Moïse
Aug 21, 2002·Circulation·Michel HaïssaguerreJacques Clémenty
Jun 1, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Akihiko NogamiKenichi Kato
May 9, 2008·The New England Journal of Medicine·Michel HaïssaguerreJacques Clémenty
Aug 16, 2008·The New England Journal of Medicine·Maurizio PieroniFilippo Crea
Jun 2, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Melvin M Scheinman
Feb 16, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Charles Antzelevitch, Gan-Xin Yan
Jun 16, 2011·Pacing and Clinical Electrophysiology : PACE·Akihiko Nogami

❮ Previous
Next ❯

Citations

Oct 21, 2016·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Yusuke FujiiMinoru Horie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.